Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
Latest in Cardiology from ACC.org
- Novel EchoNet-AS Deep Learning Model Accurately Assesses AS SeverityThe newly developed open-source EchoNet-AS deep learning model accurately assessed aortic stenosis (AS) by combining B-mode videos, Doppler images and peak aortic velocity measurements, according to research published Oct. 5 in JACC: Cardiovascular Imaging.
- SUBLIME: LIRA Method Effective, Safe and Reproducible For TAVR Patients With BAVA TAVR sizing method for bicuspid aortic valve (BAV) anatomy using the level of implantation at the raphe (LIRA) approach demonstrated favorable procedural and clinical outcomes and good reproducibility across centers, according to results from the SUBLIME study published Sept. 28 in JACC: Cardiovascular Interventions.
- ACCEL Lite: Aficamten For Symptomatic Nonobstructive HCM: ACACIA-HCM TrialIn this episode, Matthew Martinez, MD, FACC and Ahmad Masri, MD, FACC evaluate “ACACIA-HCM: Aficamten for symptomatic nonobstructive hypertrophic cardiomyopathyâ€.
- Surgical Bailout During TAVR Declining, Yet Early Mortality Remains HighThe annual incidence of surgical bailout during TAVR is declining, but short-term mortality for patients who experience emergent complications remains high, according to new data published in JACC: Cardiovascular Interventions.
- ACC Releases New Guidance For Managing Resistant HypertensionA new 2026 ACC Expert Consensus Decision Pathway focuses on “Optimizing Blood Pressure Care in Patients With Resistant Hypertension†and addresses implementation gaps not covered in the 2025 AHA/ACC/Multisociety High Blood Pressure Guideline.